Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multicolor flow cytometric analysis of LPAM-1 expression on C57BL/6 mouse bone marrow cells. Bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562302; Left Plot) or BD Horizon BV421 Rat Anti-Mouse LPAM-1 antibody (Cat. No. 562943/566294; Right Plot). Two-color flow cytometric dot plots show the correlated expression patterns of LPAM-1 (or Ig Isotype control staining) versus CD45R/B220 for gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of LPAM-1 expression on C57BL/6 mouse bone marrow cells. Bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562302; Left Plot) or BD Horizon BV421 Rat Anti-Mouse LPAM-1 antibody (Cat. No. 562943/566294; Right Plot). Two-color flow cytometric dot plots show the correlated expression patterns of LPAM-1 (or Ig Isotype control staining) versus CD45R/B220 for gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of LPAM-1 expression on C57BL/6 mouse bone marrow cells. Bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562302; Left Plot) or BD Horizon BV421 Rat Anti-Mouse LPAM-1 antibody (Cat. No. 562943/566294; Right Plot). Two-color flow cytometric dot plots show the correlated expression patterns of LPAM-1 (or Ig Isotype control staining) versus CD45R/B220 for gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of LPAM-1 expression on C57BL/6 mouse bone marrow cells. Bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562302; Left Plot) or BD Horizon BV421 Rat Anti-Mouse LPAM-1 antibody (Cat. No. 562943/566294; Right Plot). Two-color flow cytometric dot plots show the correlated expression patterns of LPAM-1 (or Ig Isotype control staining) versus CD45R/B220 for gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of LPAM-1 expression on C57BL/6 mouse bone marrow cells. Bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562302; Left Plot) or BD Horizon BV421 Rat Anti-Mouse LPAM-1 antibody (Cat. No. 562943/566294; Right Plot). Two-color flow cytometric dot plots show the correlated expression patterns of LPAM-1 (or Ig Isotype control staining) versus CD45R/B220 for gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Multicolor flow cytometric analysis of LPAM-1 expression on C57BL/6 mouse bone marrow cells. Bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV421 Rat IgG2a, κ Isotype Control (Cat. No. 562302; Left Plot) or BD Horizon BV421 Rat Anti-Mouse LPAM-1 antibody (Cat. No. 562943/566294; Right Plot). Two-color flow cytometric dot plots show the correlated expression patterns of LPAM-1 (or Ig Isotype control staining) versus CD45R/B220 for gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
For optimal and reproducible results, BD Horizon Brilliant™ Stain Buffer should be used anytime BD Horizon Brilliant™ dyes are used in a multicolor flow cytometry panel. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. When BD Horizon Brilliant Stain Buffer is used in in the multicolor panel, it should also be used in the corresponding compensation controls for all dyes to achieve the most accurate compensation. For the most accurate compensation, compensation controls created with either cells or beads should be exposed to BD Horizon Brilliant Stain Buffer for the same length of time as the corresponding multicolor panel. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The DATK32 monoclonal antibody specifically binds to an epitope specific for the α4β7 integrin heterodimer. α4β7 (LPAM-1) is expressed on most mature lymphocytes and on small subsets of thymic and bone marrow cells. It interacts with several ligands, including VCAM-1 (CD106), fibronectin, and MAdCAM-1. DATK32 antibody induces α4β7-dependent lymphocyte aggregation, but it inhibits other α4β7- mediated lymphocyte adhesion events, including binding to fibronectin, MAdCAM-1, and VCAM-1 (CD106).
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.